Author details

Full Name

Ernest Willoughby

Affiliation

ORCID

Career Start Year

1978

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34566866	MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.	Front Neurol	2021
33704407	The latitude gradient for multiple sclerosis prevalence is established in the early life course.	Brain	2021
32612571	Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.	Front Neurol	2020
32006158	The clinical profile of NMOSD in Australia and New Zealand.	J Neurol	2020
32547777	Regarding the publication The Multiple Sclerosis Severity Score: Fluctuations and prognostic ability in a longitudinal cohort of patients with MS authored by RH Gross .	Multiple Sclerosis Journal - Experimental, Translational and Clinical	2020
28550069	Incidence and prevalence of NMOSD in Australia and New Zealand.	J Neurol Neurosurg Psychiatry	2017
26224184	A new era in the treatment of multiple sclerosis.	Med J Aust	2015
25304432	Congestive myeloradiculopathy in a patient with Cowden syndrome.	Journal of Clinical Neuroscience	2015
24986155	Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.	J Clin Neurosci	2014
24993136	Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists.	J Clin Neurosci	2014
24993135	Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists.	J Clin Neurosci	2014
21689501	American academy of neurology annual meeting.	International MS Journal	2011
22190364	Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.	Ann Neurol	2011
21833088	Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.	Nature	2011
18782504	American Academy of Neurology (AAN) 60th Annual Meeting. 12 to 19 April 2008.	International MS Journal	2008
18256342	A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue.	Psychosomatic Medicine	2008
11796762	Modafinil for fatigue in multiple sclerosis.	Journal of Neurology, Neurosurgery and Psychiatry	2002
10403069	Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group.	Cephalalgia	1999
10355672	Development of a multiple sclerosis functional composite as a clinical trial outcome measure.	Brain	1999
9595867	Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.	Headache	1998
9223207	Late recurrence of postdural puncture headache.		1997
9307263	Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.	Ann Neurol	1997
8797541	Clinical outcomes assessment in multiple sclerosis.	Ann Neurol	1996
7325607	Human leukocyte anitgen in torticollis and other idiopathic dystonic syndromes.	Annals of Neurology	1981
6987549	Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus.	Neurology	1980
79763	Coma in the Wernicke-Korsakoff syndrome.	Lancet, The	1978